Education
About Us
Working with TipRanks
Follow Us
Candel Therapeutics (CADL)
NASDAQ:CADL
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 125.00K | $ 125.00K | $ 125.00K |
| Gross Profit | $ 0.00 | $ -23.98M | $ -862.00K | $ -107.00K | $ 125.00K |
| Operating Income | $ -33.37M | $ -38.39M | $ -34.72M | $ -25.73M | $ -13.81M |
| EBITDA | $ -52.10M | $ -37.43M | $ -17.32M | $ -25.49M | $ -13.72M |
| Net Income | $ -55.18M | $ -37.94M | $ -2.87M | $ -36.18M | $ -22.17M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 102.65M | $ 35.41M | $ 70.06M | $ 82.64M | $ 35.05M |
| Total Assets | $ 106.87M | $ 41.20M | $ 77.69M | $ 89.20M | $ 38.28M |
| Total Debt | $ 13.47M | $ 22.76M | $ 22.80M | $ 560.00K | $ 946.00K |
| Net Debt | $ -89.18M | $ -12.65M | $ -47.26M | $ -82.08M | $ -34.11M |
| Total Liabilities | $ 40.54M | $ 28.46M | $ 29.98M | $ 25.07M | $ 61.84M |
| Stockholders' Equity | $ 66.33M | $ 12.74M | $ -99.09M | $ 64.14M | $ -23.56M |
| Cash Flow | |||||
| Free Cash Flow | $ -27.04M | $ -34.70M | $ -32.72M | $ -24.05M | $ -10.55M |
| Operating Cash Flow | $ -27.02M | $ -34.24M | $ -31.42M | $ -22.22M | $ -9.07M |
| Investing Cash Flow | $ -16.00K | $ -280.00K | $ -1.30M | $ -1.83M | $ 38.45M |
| Financing Cash Flow | $ 94.28M | $ -121.00K | $ 19.97M | $ 71.80M | $ 490.00K |